Sitka 14s 100 mg film-coated tablets

The instruction for medical use of medicine the Sitcom the Trade name the Sitcom the International unlicensed name Is not present the Dosage form of the Tablet, film coated, 100 mg Structure One film coated tablet contains active agent – the euphorbia creeping herbs dry extract of 100.0 mg, excipients – Mannitolum, cellulose microcrystalline, starch prezhelatinizirovanny, sodium of a kroskarmelloz, a glitserol dibegenat, silicon dioxide colloidal anhydrous, magnesium stearate, krospovidon. structure of a cover – the main covering Opadri of II 85G68918 (white), a final covering of Opadri of AMB 80W51484 (green) and S-117823 Opakod ink (black) structure of the main covering Opadri of II 85G68918 (white) – polyvinyl alcohol **, the titan dioxide (E171), talc (1520), macrogoal/PEG 3350 (E553b), lecithin (E322). structure of a final covering of Opadri of AMB 80W51484 (green) – polyvinyl alcohol **, the titan dioxide (E171), talc (E553b), ferrous oxide yellow (E172), lecithin (E322), FD&C Blue No. 2/the Aluminium Pigment, Indigo carmine (E132), xanthan Din (E415). composition of S-117823 Opakod ink (black) – shellac glaze of-45%, alcohol izoprilovy **, ferrous oxide black (E172), alcohol n-butyl **, propylene glycol, ammonium chloride of 28%. ** - evaporates in the course of production. The description of the Tablet of an oval form, with a biconvex surface, film coated greenish color, with an inscription black ERT ink on one party and smooth from other party. Pharmacotherapeutic group Other means for treatment of hemorrhoids and anal cracks for topical administration. Other drugs and their combination. The ATX C05AX03 code the Pharmacological Euphorbia Pharmacokinetics properties creeping herbs extract of dry (Euphorbia prostrata) contains a complex of biologically active agents among which: polyphenolic substances (lyuteolin, 6-metoksikvertsetinglikozid, meletin and glycosides of a lyuteolin and an apigenin), bioflavonoids, and effect of drug it is caused by cumulative action of all its components, carrying out kinetic researches is not possible. A pharmacodynamics the Pharmacological effect of drug is caused by a complex of biologically active agents of the euphorbia creeping herbs extract of dry (Euphorbia prostrata) which are a part having the anti-inflammatory, anesthetizing, haemo static, antitrombotichesky properties. Bioflavonoids lyuteolin, 6-metoksikvertsetinglikozid, meletin and glycosides of a lyuteolin and an apigenin are antioxidants with anti-inflammatory action. Lyuteolin and apigenin promote metabolism of carbohydrates, interfere with production and secretion of anti-inflammatory FNO-α cytokines and IL-1β, IL-6, IL-4, IL-13 interleukins. Apigenin blocks forming of uric acid. Meletin slows down synthesis and secretion of a histamine, inhibits enzyme a lipoxygenase and CYP3A4 cytochrome. Drug has the anti-inflammatory, anesthetizing effect, prevents bleeding, reduces permeability of capillaries. Indications hemorrhoids 1 and 2 degrees hemorrhoids 3 and 4 degrees and after a gemorroidoektomiya for the purpose of symptomatic simplification of a condition of the patient the Route of administration and doses of the Tablet Sitcom are intended for intake. A pill can be taken regardless of reception write. Treatment of hemorrhoids 1 and 2 degrees: on one tablet (100 mg) once a day within 14 days. For patients with a postgemorroidektomialny state and in hemorrhoids 3 and 4 degrees: on one tablet (100 mg) twice a day within 14 days. Side effects nausea, dyspepsia, an abdominal pain, a gastralgia, gastritis, a diarrhea, dryness in a mouth dizziness, a headache allergic reactions, hypersensitivity of the Contraindication hypersensitivity to drug components pregnancy and the period of a lactation children's age up to 18 years Medicinal interactions of the Tablet SITCOM change a coagulative profile of blood therefore they need to be applied with care together with anticoagulants and platelet antiagregantnym means. Interaction the SITCOM with other medicines is not established. Special instructions Patients with signs of disturbance of hepatic and/or renal function should be careful at reception of the tablet SITCOM. Careful monitoring of function of a liver and kidneys is necessary. Features of influence of medicine on ability to run the vehicle and potentially dangerous mechanisms the Overdose Symptoms does not influence: nausea, dyspepsia, an abdominal pain, a gastralgia, gastritis, a diarrhea, dizziness, a headache, allergic reaction, hypersensitivity, dryness in a mouth. Treatment: drug withdrawal, symptomatic therapy. The form of release and packing On 7 tablets place in blister strip packaging (blister) from a white opaque film of polyvinyldichloride, covered with a layer Aklar/of polyvinylchloride. On 2 blister strip packagings together with the instruction for medical use in the state and Russian languages place in a pack from cardboard. To Store storage conditions in the dry, protected from light place, at a temperature not above 30 °C. To store out of children's reach! A period of storage 2 years not to apply after the expiry date specified on packing Prescription status According to the prescription the Name and the country of the Panatseya Biotek Ltd. manufacturing organization, Malpur, Buddy, Tekhsil Nalagarkh, the Region of Solan (H.P.) – 173205, India the Name and the country of the owner of the registration certificate of Panatseya Biotek Ltd, India the Name and the country of the Panatseya Biotek Ltd organization packer, India the Address of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of products (goods) of Koral-Med Kazakhstan LLP Almaty, Auezov St. 3